50% Fewer Resources, 100% of Goal

What do you do when you have a new indication to launch for your brand and your field force has just been cut in half? Oh, and did I mention that your launch goal for the first 90 days stayed the same? I recently spoke with a brand director who is faced with this situation. He actually has two new indications with a third pending that will be of enormous benefit to his brand, but he's coming up short on getting the word out with reps.

This is the perfect scenario for leveraging precision non-personal promotions. Through our partnership with IMS Health, RMI can identify the most opportunistic prescribers based upon some key clinical events. With the client mentioned above, there is a test patients are given to determine their propensity for a gene mutation that will cause a rash during treatment. If the patient is identified as at-risk, a proactive treatment regimen is prescribed to avoid the rash, ultimately enabling the therapy to be more efficacious. Through claims data, we can identify when the test is ordered, which is a trigger event for prescribing this company's drug. What could be more ideal? We use a triggered, customized, non-personal contact to reach a doctor who is in decision-making mode with an ill patient.

We have several programs where non-personal promotion is triggered based upon specific clinical events such as titration. Using Anonymized Patient Level Data (APLD), we can identify titration or concomitant use -- indicators a prescriber may consider alternative brands. If you're facing any of these scenarios, please give me a call at 866.446.6688 x 174 and I'd be happy to discuss your market situation and brand to find a strategic way to leverage non-personal promotion in your brand plan.